We showed that BZ indeed induced GR accumulation in lymphoma, leukemia and prostate cancer cells, and enhanced CpdA's profile as a dissociated GR ligand further shifting GR signaling to TR [35, 39, 83]. This evidence concerns the gene NR3C1 and prostate carcinoma.